Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (9): 872-879.doi: 10.19982/j.issn.1000-6621.20230115
• Original Articles • Previous Articles Next Articles
Li Yamin, Gao Zhidong(), Li Yanyuan, Tao Liying, Zhao Xin
Received:
2023-04-14
Online:
2023-09-10
Published:
2023-09-01
Contact:
Gao Zhidong, Email: Supported by:
CLC Number:
Li Yamin, Gao Zhidong, Li Yanyuan, Tao Liying, Zhao Xin. Effectiveness of WeChat and electronic pillbox in strengthening supervision management for pulmonary tuberculosis patients in Beijing[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 872-879. doi: 10.19982/j.issn.1000-6621.20230115
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230115
治疗时间 | 微信 | 电子药盒 | 合计 | ||||||
---|---|---|---|---|---|---|---|---|---|
服药次数 | 打卡次数 | 打卡率(%) | 服药次数 | 打卡次数 | 打卡率(%) | 服药次数 | 打卡次数 | 打卡率(%) | |
疗程开始时 | 134 | 134 | 100.0 | 381 | 381 | 100.0 | 515 | 515 | 100.0 |
1周末 | 938 | 754 | 80.4 | 2667 | 2222 | 83.3 | 3605 | 2976 | 82.6 |
2周末 | 1862 | 1435 | 77.1 | 5334 | 4357 | 81.7 | 7196 | 5792 | 80.5 |
1个月末 | 3990 | 2901 | 72.7 | 11340 | 8963 | 79.0 | 15330 | 11864 | 77.4 |
2个月末 | 7860 | 5502 | 70.0 | 22440 | 16193 | 72.2 | 30330 | 21725 | 71.6 |
3个月末 | 11700 | 7773 | 66.4 | 33390 | 22251 | 66.6 | 45090 | 30024 | 66.6 |
4个月末 | 15360 | 9641 | 62.8 | 44040 | 27437 | 62.3 | 59400 | 37078 | 62.4 |
5个月末 | 19050 | 11185 | 58.7 | 54750 | 31738 | 58.0 | 73800 | 42923 | 58.2 |
6个月末 | 22140 | 12249 | 55.3 | 60300 | 34083 | 56.5 | 82440 | 46332 | 56.2 |
7个月末 | 20160 | 11308 | 56.1 | 51240 | 28552 | 55.7 | 71400 | 39860 | 55.8 |
8个月末 | 21840 | 12060 | 55.2 | 49200 | 25709 | 52.3 | 71040 | 37769 | 53.2 |
疗程结束 | 37303 | 17049 | 45.7 | 101610 | 46173 | 45.4 | 138913 | 63222 | 45.5 |
Z值 | -62.182 | -117.843 | -133.070 | ||||||
P值 | <0.001 | <0.001 | <0.001 |
变量名称 | 赋值 | 变量名称 | 赋值 |
---|---|---|---|
因变量 | 未规则打卡=0;规则打卡=1 | 诊断结果 | 病原学阳性=1;病原学阴性=2;无病原学结果=3;结核性胸膜炎=4 |
自变量 | |||
治疗分类 | 初治=1;复治=2 | ||
性别 | 男=1;女=2 | ||
并发症 | 无=0;有=1 | ||
年龄 | 18~30岁=1;30~60岁=2;≥60岁=3 | ||
合并其他结核 | 无=0;有=1 | ||
民族 | 汉族=1;少数民族=2 | ||
职业 | 在职人员=1;离退人员=2;农牧渔民=3;学生=4;家务及待业人员=5 | ||
就诊时间 | 定量资料,从出现症状到就诊的时间 | ||
确诊时间 | 定量资料,从就诊到确诊的时间 | ||
户籍 | 外地=1;北京市=2 | ||
智能工具类型 | 微信=1;电子药盒=2 | ||
首诊单位性质 | 市级定点=1;区级定点=2;结核病防治机构=3 |
因素 | 规则打卡 | 未规则打卡 | 合计 | 统计检验值 | P值 |
---|---|---|---|---|---|
性别[例(构成比,%)] | χ2=0.391 | 0.532 | |||
男性 | 80(24.2) | 251(75.8) | 331 | ||
女性 | 40(21.7) | 144(78.3) | 184 | ||
年龄 [例(构成比,%)] | χ2=18.726 | <0.001 | |||
<30岁 | 21(12.2) | 151(87.8) | 172 | ||
30~60岁 | 68(30.5) | 155(69.5) | 223 | ||
≥60岁 | 31(25.8) | 89(74.2) | 120 | ||
职业[例(构成比,%)] | χ2=18.704 | <0.001 | |||
在职人员 | 44(19.9) | 177(80.1) | 221 | ||
离退人员 | 9(14.1) | 55(85.9) | 64 | ||
农牧渔民 | 31(39.7) | 47(60.3) | 78 | ||
学生 | 2(10.0) | 18(90.0) | 20 | ||
家务及待业 | 34(25.8) | 98(74.2) | 132 | ||
户籍[例(构成比,%)] | χ2=10.115 | 0.002 | |||
北京市 | 69(29.9) | 162(70.1) | 231 | ||
外地 | 51(18.0) | 233(82.0) | 284 | ||
民族[例(构成比,%)] | -a | 0.628a | |||
汉族 | 118(23.2) | 391(76.8) | 509 | ||
少数民族 | 2(33.3) | 4(66.7) | 6 | ||
首诊单位性质[例(构成比,%)] | χ2=31.001 | <0.001 | |||
市级定点 | 63(24.8) | 191(75.2) | 254 | ||
区级定点 | 13(76.5) | 4(23.5) | 17 | ||
结核病防治机构 | 44(18.0) | 200(82.0) | 244 | ||
诊断结果[例(构成比,%)] | χ2=6.658 | 0.084 | |||
病原学阳性 | 69(25.6) | 201(74.4) | 270 | ||
病原学阴性 | 34(19.3) | 142(80.7) | 176 | ||
无病原学结果 | 12(35.3) | 22(64.7) | 34 | ||
结核性胸膜炎 | 5(14.3) | 30(85.7) | 35 | ||
治疗分类[例(构成比,%)] | χ2=0.001 | 0.982 | |||
初治 | 116(23.3) | 382(76.7) | 498 | ||
复治 | 4(23.5) | 13(76.5) | 17 | ||
并发症[例(构成比,%)] | χ2=0.431 | 0.512 | |||
无 | 104(22.9) | 351(77.1) | 455 | ||
有 | 16(26.7) | 44(73.3) | 60 | ||
合并其他结核[例(构成比,%)] | χ2=9.631 | 0.002 | |||
无 | 90(20.8) | 343(79.2) | 433 | ||
有 | 30(36.6) | 52(63.4) | 82 | ||
就诊时间[d,M(Q1,Q3)] | 4(0,27) | 2(0,23) | 3(0,24) | Z=-1.517 | 0.129 |
确诊时间[d,M(Q1,Q3)] | 7(0,17.5) | 7(0,16) | 7(0,16) | Z=-0.871 | 0.384 |
智能工具类型[例(构成比,%)] | χ2=0.586 | 0.444 | |||
微信 | 28(20.9) | 106(79.1) | 134 | ||
电子药盒 | 92(24.1) | 289(75.9) | 381 |
[1] | World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022. |
[2] | 北京市卫生健康委信息中心, 北京市卫生健康大数据与政策研究中心. 2021年北京市卫生健康事业发展统计公报[EB/OL]. [2022-02-01]. http://www.phic.org.cn/tjsj/wstjgb/202203/P020220316647704704042.pdf. |
[3] | 中华人民共和国国家卫生和计划生育委员会. 国家卫生计生委关于印发《国家基本公共卫生服务规范(第三版)》的通知. 国卫基层发〔2017〕13号. 2017-02-28. |
[4] | 北京市卫生健康委办公室. 北京市卫生健康委员会关于印发北京市结核病防治工作规范(2020年版)的通知. 京卫疾控〔2020〕71号. 2020-09-09. |
[5] |
李雪, 姜世闻, 胡冬梅, 等. 电子药盒和手机微信APP的应用对肺结核患者服药依从性的效果评价. 中国防痨杂志, 2019, 41(9): 957-961. doi:10.3969/j.issn.1000-6621.2019.09.009.
doi: 10.3969/j.issn.1000-6621.2019.09.009 |
[6] |
李亚敏, 高志东, 陈曦, 等. 移动互联网技术用于社区肺结核患者健康管理的接受意愿调查分析. 中国防痨杂志, 2020, 42(12): 1313-1317. doi:10.3969/j.issn.1000-6621.2020.12.012.
doi: 10.3969/j.issn.1000-6621.2020.12.012 |
[7] |
王倪, 张慧, 张铁娟, 等. 使用电子药盒辅助肺结核患者服药管理的实施情况分析. 中国防痨杂志, 2020, 42(7): 682-686. doi:10.3969/j.issn.1000-6621.2020.07.008.
doi: 10.3969/j.issn.1000-6621.2020.07.008 |
[8] |
杨帆, 马建军, 高迎, 等. 吉林省结核病患者全面推广电子药盒后的使用率及影响因素分析. 中国防痨杂志, 2022, 44(10): 1050-1056. doi:10.19982/j.issn.1000-6621.20220080.
doi: 10.19982/j.issn.1000-6621.20220080 |
[9] |
李勇, 路丽苹, 李瑾, 等. 肺结核患者对结核助手APP和电子药盒的使用意愿和效果分析. 结核与肺部疾病杂志, 2022, 3(1): 22-26. doi:10.19983/j.issn.2096-8493.20210110.
doi: 10.19983/j.issn.2096-8493.20210110 |
[10] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[11] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[12] | World Health Organization. Guidelines for drug susceptible tuberculosis and patient care. Geneva: World Health Organization, 2017. |
[13] |
郝晓刚, 王炜, 张幸, 等. 应用电子药盒辅助肺结核患者服药管理的实施情况研究. 中国防痨杂志, 2022, 44(1): 110-112. doi:10.19982/j.issn.1000-6621.20210339.
doi: 10.19982/j.issn.1000-6621.20210339 |
[14] |
景睿, 曹艳民, 杨一军, 等. 电子药盒和手机微信APP对肺结核患者督导服药管理的应用研究. 结核与肺部疾病杂志, 2020, 1(1): 96-99. doi:10.3969/j.issn.2096-8493.2020.01.020.
doi: 10.3969/j.issn.2096-8493.2020.01.020 |
[15] |
薛晓, 张东彦, 艾萍, 等. 肺结核患者电子药盒和微信小程序使用情况分析. 中国防痨杂志, 2022, 44(7): 704-710. doi:10.19982/j.issn.1000-6621.20220102.
doi: 10.19982/j.issn.1000-6621.20220102 |
[16] |
李智, 周惠, 陈晓军, 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019, 41(9): 1015-1020. doi:10.3969/j.issn.1000-6621.2019.09.019.
doi: 10.3969/j.issn.1000-6621.2019.09.019 |
[17] | 桓世彤, 陈嵘, 刘小秋, 等. 电子药盒取药记录监测肺结核患者服药行为的可行性评估. 中国防痨杂志, 2012, 34(7): 419-424. |
[18] |
Liu X, Lewis JJ, Zhang H, et al. Effectiveness of Electronic Reminders to Improve Adherence in Tuberculosis Patients: A Cluster-Randomised Trail. PLoS Med, 2015, 12(9): e1001876. doi:10.1371/journal.pmed.1001876.
doi: 10.1371/journal.pmed.1001876 URL |
[19] |
Wu Z, Lu L, Li Y, et al. Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study. Front Public Health, 2023, 11: 923319. doi:10.3389/fpubh.2023.923319.
doi: 10.3389/fpubh.2023.923319 URL |
[20] |
Liu X, Thompson J, Dong H, et al. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial. Lancet Glob Health, 2023, 11(5): e693-e703. doi:10.1016/s2214-109x(23)00068-2.
doi: 10.1016/S2214-109X(23)00068-2 pmid: 37061308 |
[1] | XUE Xiao, ZHANG Dong-yan, AI Ping, DENG Ling, CHEN Wei, HU Yuan-lian, JIA Xue-jiao, YANG Guo-liang, XIN Zhen-jiang, CHANG Li-jie. Analysis of the usage of electronic pillbox and WeChat App in pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 704-710. |
[2] | HU Yuan-lian, DENG Ling, AI Ping, JIA Xue-jiao, CHEN Wei, ZHANG Dong-yan, XUE Xiao, WU Qian-yu, XIE Jun-qing. Survey on the community treatment and management of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 473-477. |
[3] | TIAN Xiao-mei, LEI Juan, LIU Jing, LIU Guang-tian, PAN Li, LIU Tao, SHI Feng, WANG Xiao-lin. Analysis on the effect of diagnosis and treatment management of rifampicin-resistant pulmonary tuberculosis and financing mode in Ningxia [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 772-777. |
[4] | FAN Jun, ZHANG Wen, ZHANG Ting, WANG Qing-ya, YU Ya, CHENG Jun. Analysis on characteristics of reported pulmonary tuberculosis among students in Chongqing from 2008 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 716-723. |
[5] | ZHOU Shuang, CHEN Nan, ZHU Kun, JIANG Hui, YANG Lei, DU Jian. Investigation of the experience of tuberculosis patients for follow up using the internet platform [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 398-403. |
[6] | KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong. Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118. |
[7] | YING Ruo-yan, HUANG Xiao-chen, WANG Jie, LIU Yi-dian, SHA Wei, YANG Hua. Analysis of the correlation between sensitivity of drugs in the treatment and the outcome of treatment in pulmonary tuberculosis patients retreated for the first time [J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1001-1005. |
[8] | ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915. |
[9] | MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925. |
[10] | LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936. |
[11] | DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961. |
[12] | ZHONG Qian-hong, MA Xiao-hui, LIN Zhi-hao, LI Yi, ZHOU Jie, DENG Dong-hua, DENG Ci-xi, LIANG Xiao-min. Evaluation of the application of Foshan Tuberculosis Surveillance and Management Platform in tuberculosis prevention and treatment [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 653-656. |
[13] | LI Xiao-kun, YUAN Yan-li, YANG Guang-xu, WU Yuan-yuan. Design and application of Tuberculosis Designated Hospital Information Management Platform in Changchun [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 671-675. |
[14] | LIU Guang-tian, LIU Tao, WANG Xiao-wei, LEI Juan, TIAN Xiao-mei, WANG Xiao-lin. Application of “Internet+Medical Treatment” model in tuberculosis prevention and treatment in Ningxia [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 676-681. |
[15] | WANG Ni, ZHANG Hui, ZHANG Tie-juan, CHEN Bin, LEI Juan, SUN Miao-miao, HUANG Fei. Analysis of using electronic pillbox to assist the medication management of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 682-686. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||